Myriad Genetics, Inc. MYGN recently announced the receipt of additional reimbursement in Japan for its myChoice Diagnostic System. Notably, the test aids in identifying patients with advanced ovarian ...
Men with PCA or at risk for PCA (family history of PCA) were eligible and could choose pretest VBGE or GC. Outcomes included decisional conflict for GT, change in genetics knowledge, satisfaction, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback